NCT04444921 2026-04-13EA2176: Phase 3 Clinical Trial of Carboplatin and Paclitaxel +/- Nivolumab in Metastatic Anal Cancer PatientsNational Cancer Institute (NCI)Phase 3 Active not recruiting205 enrolled
NCT04472429 2025-11-03Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (POD1UM-303/InterAACT 2).Incyte CorporationPhase 3 Completed308 enrolled 17 charts 3 FDA